BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 27976881)

  • 1. Photodynamic Therapy Mediated by Nontoxic Core-Shell Nanoparticles Synergizes with Immune Checkpoint Blockade To Elicit Antitumor Immunity and Antimetastatic Effect on Breast Cancer.
    Duan X; Chan C; Guo N; Han W; Weichselbaum RR; Lin W
    J Am Chem Soc; 2016 Dec; 138(51):16686-16695. PubMed ID: 27976881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Core-shell nanoscale coordination polymers combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapy.
    He C; Duan X; Guo N; Chan C; Poon C; Weichselbaum RR; Lin W
    Nat Commun; 2016 Aug; 7():12499. PubMed ID: 27530650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis.
    Kim S; Kim SA; Nam GH; Hong Y; Kim GB; Choi Y; Lee S; Cho Y; Kwon M; Jeong C; Kim S; Kim IS
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33479026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of a novel heat shock protein 90-targeted photodynamic therapy with PD-1/PD-L1 blockade induces potent systemic antitumor efficacy and abscopal effect against breast cancers.
    Kaneko K; Acharya CR; Nagata H; Yang X; Hartman ZC; Hobeika A; Hughes PF; Haystead TAJ; Morse MA; Lyerly HK; Osada T
    J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36171008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune Checkpoint Blockade Mediated by a Small-Molecule Nanoinhibitor Targeting the PD-1/PD-L1 Pathway Synergizes with Photodynamic Therapy to Elicit Antitumor Immunity and Antimetastatic Effects on Breast Cancer.
    Zhang R; Zhu Z; Lv H; Li F; Sun S; Li J; Lee CS
    Small; 2019 Dec; 15(49):e1903881. PubMed ID: 31702880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photodynamic therapy synergizes with PD-L1 checkpoint blockade for immunotherapy of CRC by multifunctional nanoparticles.
    Yuan Z; Fan G; Wu H; Liu C; Zhan Y; Qiu Y; Shou C; Gao F; Zhang J; Yin P; Xu K
    Mol Ther; 2021 Oct; 29(10):2931-2948. PubMed ID: 34023507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemo-photodynamic therapy with light-triggered disassembly of theranostic nanoplatform in combination with checkpoint blockade for immunotherapy of hepatocellular carcinoma.
    Xu J; Zheng Q; Cheng X; Hu S; Zhang C; Zhou X; Sun P; Wang W; Su Z; Zou T; Song Z; Xia Y; Yi X; Gao Y
    J Nanobiotechnology; 2021 Oct; 19(1):355. PubMed ID: 34717654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prodrug hydrogel with tumor microenvironment and near-infrared light dual-responsive action for synergistic cancer immunotherapy.
    Ding M; Fan Y; Lv Y; Liu J; Yu N; Kong D; Sun H; Li J
    Acta Biomater; 2022 Sep; 149():334-346. PubMed ID: 35779775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing Anti-PD-1/PD-L1 Immune Checkpoint Inhibitory Cancer Therapy by CD276-Targeted Photodynamic Ablation of Tumor Cells and Tumor Vasculature.
    Bao R; Wang Y; Lai J; Zhu H; Zhao Y; Li S; Li N; Huang J; Yang Z; Wang F; Liu Z
    Mol Pharm; 2019 Jan; 16(1):339-348. PubMed ID: 30452269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomimetic Nanoemulsion for Synergistic Photodynamic-Immunotherapy Against Hypoxic Breast Tumor.
    Zhang Y; Liao Y; Tang Q; Lin J; Huang P
    Angew Chem Int Ed Engl; 2021 May; 60(19):10647-10653. PubMed ID: 33555085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibiting Metastasis and Preventing Tumor Relapse by Triggering Host Immunity with Tumor-Targeted Photodynamic Therapy Using Photosensitizer-Loaded Functional Nanographenes.
    Yu X; Gao D; Gao L; Lai J; Zhang C; Zhao Y; Zhong L; Jia B; Wang F; Chen X; Liu Z
    ACS Nano; 2017 Oct; 11(10):10147-10158. PubMed ID: 28901740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide vaccine-conjugated mesoporous carriers synergize with immunogenic cell death and PD-L1 blockade for amplified immunotherapy of metastatic spinal.
    Wang Z; Chen L; Ma Y; Li X; Hu A; Wang H; Wang W; Li X; Tian B; Dong J
    J Nanobiotechnology; 2021 Aug; 19(1):243. PubMed ID: 34384429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Near-Infrared-Triggered Photodynamic Therapy with Multitasking Upconversion Nanoparticles in Combination with Checkpoint Blockade for Immunotherapy of Colorectal Cancer.
    Xu J; Xu L; Wang C; Yang R; Zhuang Q; Han X; Dong Z; Zhu W; Peng R; Liu Z
    ACS Nano; 2017 May; 11(5):4463-4474. PubMed ID: 28362496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potentiated checkpoint blockade immunotherapy by ROS-responsive nanocarrier-mediated cascade chemo-photodynamic therapy.
    Hu L; Cao Z; Ma L; Liu Z; Liao G; Wang J; Shen S; Li D; Yang X
    Biomaterials; 2019 Dec; 223():119469. PubMed ID: 31520886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-metastatic and pro-apoptotic effects elicited by combination photodynamic therapy with sonodynamic therapy on breast cancer both in vitro and in vivo.
    Wang P; Li C; Wang X; Xiong W; Feng X; Liu Q; Leung AW; Xu C
    Ultrason Sonochem; 2015 Mar; 23():116-27. PubMed ID: 25465095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photothermally activatable PDA immune nanomedicine combined with PD-L1 checkpoint blockade for antimetastatic cancer photoimmunotherapy.
    Lu Q; Qi S; Li P; Yang L; Yang S; Wang Y; Cheng Y; Song Y; Wang S; Tan F; Li N
    J Mater Chem B; 2019 Apr; 7(15):2499-2511. PubMed ID: 32255127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visible-Light-Triggered Prodrug Nanoparticles Combine Chemotherapy and Photodynamic Therapy to Potentiate Checkpoint Blockade Cancer Immunotherapy.
    Choi J; Shim MK; Yang S; Hwang HS; Cho H; Kim J; Yun WS; Moon Y; Kim J; Yoon HY; Kim K
    ACS Nano; 2021 Jul; 15(7):12086-12098. PubMed ID: 34165970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifunctional Nanoparticles-Mediated PTT/PDT Synergistic Immune Activation and Antitumor Activity Combined with Anti-PD-L1 Immunotherapy for Breast Cancer Treatment.
    Kong C; Xu B; Qiu G; Wei M; Zhang M; Bao S; Tang J; Li L; Liu J
    Int J Nanomedicine; 2022; 17():5391-5411. PubMed ID: 36419717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoscale Metal-Organic Frameworks for Cancer Immunotherapy.
    Ni K; Luo T; Nash GT; Lin W
    Acc Chem Res; 2020 Sep; 53(9):1739-1748. PubMed ID: 32808760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer-cell-biomimetic Upconversion nanoparticles combining chemo-photodynamic therapy and CD73 blockade for metastatic triple-negative breast cancer.
    Jin F; Qi J; Liu D; You Y; Shu G; Du Y; Wang J; Xu X; Ying X; Ji J; Du Y
    J Control Release; 2021 Sep; 337():90-104. PubMed ID: 34274385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.